Inicio > Microbiología y Parasitología > Microalgas y cianobacterias. Aplicación en Medicina > Página 4

Microalgas y cianobacterias. Aplicación en Medicina

  • hypercholesterolemic healthy individuals. Arterioscler. Thromb. Vasc. Biol. (24):25–28.
  • Francisco E, Neves D, Jacob-Lopes E, Franco T. (2010).Microalgae as feedstock for biodiesel production: Carbon dioxide sequestration, lipid production and biofuel quality. Chem Technol Biotechnol (85):395–403
  • Gallardo-Casas CA, Cano-Europa E, Lopez-Galindo GE, Blas-Valdivia V, Olvera-Ramírez R, Franco-Colín M, Ortiz-Butrón R. (2011). Las ficobiliproteínas de Spirulina maxima y Pseudanabaena tenuis protegen contra el daño hepático y el estrés oxidativo ocasionado por el Hg2+. Rev Mex Cienc Farm. 41(2):30-35.
  • Gogus U, Smith C. (2010). n-3 Omega fatty acids: Are vie w of current knowledge. International Journal of Food Science and Technology. (45):417–436.
  • Guedes ACA. (2010). Production, extraction and characterization of selected metabolites from microalgae and cyanobacteria. PhD ThesisPorto, Portugal: Escola Superior de Biotecnologia, Universidade Católica Portuguesa.
  • Guerin M, Huntley ME, Olaizola M. (2003). Haematococcus astaxanthin: applications for human health and nutrition. Trends in Biotechnol. 21(5):210-216.
  • Hu FB, Bronner L, Willet WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE. (2002). Fish and omega−3 fatty acid intake and risk of coronary heart disease in women. J Am Med Assoc. (287):1815–1821.
  • Jacob-Lopes E, Zepka LQ, Queiroz MI, Pinto LAA. (2007). Characteristics of thin-layer drying of the cyanobacterium Aphanothece microscopica Nägaeli. Chemical Engineering and Processing. (46):63-69.
  • Loke MF, Lui SY, Ng BL, Gong M, Ho B. (2007). Antiadhesive property of microalgal polysaccharide extract on the binding of Helicobacter pylori to gastric mucin. FEMS Immunol. Med. Microbiol. (50):231–23
  • Montpoint S, Guilhou JJ. (1991). Les microalgues: applications potentielles en dermatologie. Premier Colloque Scientifique Français sur la Biotechnologie des Microalgues et des Cyanobacteries Appliquée au Thermalisme. Amélie-les-bains: Centre d’Études Nucléaires de Cadarache; p. 93–6. [24 et 25 Octobre].
  • Olaizola M. (2003). Commercial development of microalgal biotechnology: from the test tube to the marketplace. Biomol. Eng. 20, 459–466
  • Perez-Garcia O, Escalante FME, de-Bashan LE, Bashan Y. (2011). Heterotrophic cultures of microalgae: metabolism and potential products. Water Res. 45(1): 11–36.
  • Pulz O, Gross W. (2004). Valuable products from biotechnology of microalgae. Appl Microbiol Biotechnol. (65):635–48.
  • Raposo M, Morais RSC, Morais AMMB. (2013). Health applications of bioactive compounds from marine microalgae. Life Sciences. (93):479–486
  • Sharma MK, Sharma A, Kumar A, Kumar M. (2007). Evaluation of protective efficacy of Spirulina fusiformis against mercury induced nephrotoxicity in Swiss albino mice. Food and Chem Toxicol. 45(6):879-887.
  • Sheih, IC, Fang T, Wu TK, Lin PH. (2010). Anticancer and antioxidant activities of the peptide fraction from algae protein waste. J. Agric. Food Chem. 58 (2):1202–1207.
  • Washida K, Koyama T, Yamada K, Kitab M, Urmura D. (2006). Karatungiols A and B, two novel antimicrobial polyol compounds, from the symbioticmarine dinoflagellate Amphidinium sp. Tetrahedron Lett. 47(15):2521–5.
  • Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH. (2009). Omega-3 fatty acids: A comprehensive review of their role in health and disease. Postgraduate Medical Journal. (85):84–90.
  • Zepka LQ, Queiroz MI, Jacob-Lopes E, Goldbeck R. (2010). Nutricional evaluation of single-cell protein produced by Aphanothece microscopica Nägaeli. Bioresource Technology. (101):7107-7111.